⌘K

Login Start Free

Home/Filings/4/0001415889-25-024319

4//SEC Filing

Higgins Jack 4

Accession 0001415889-25-024319

CIK 0001472012other

View on SEC.gov Company Profile

Filed

Sep 10, 8:00 PM ET

Accepted

Sep 11, 9:04 PM ET

Size

6.9 KB

Accession

0001415889-25-024319

Insider Transaction Report

Form 4

Period: 2025-09-10

Immunome Inc.IMNM

Chief Scientific Officer

Transactions

Exercise/Conversion
Common Stock
2025-09-10$1.35/sh+22,000$29,700→ 40,729 total
Exercise/Conversion
Employee Stock option (right to buy)
2025-09-10−22,000→ 151,840 total
Exercise: $1.35Exp: 2032-06-23→ Common Stock (22,000 underlying)

Footnotes (1)

[F1]25% of the shares vested on May 1, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter.

Documents

1 file

4
form4-09122025_010912.xmlPrimary

Issuer

Immunome Inc.

CIK 0001472012

Entity typeother

Related Parties

1

filerCIK 0001993684

Filing Metadata

Form type: 4
Filed: Sep 10, 8:00 PM ET
Accepted: Sep 11, 9:04 PM ET
Size: 6.9 KB

View on SEC.gov